| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3030193 | Thrombosis Research | 2007 | 6 Pages |
Abstract
Patients with CAD after a first myocardial infarction and hyperhomocysteinemia show a reduced t-PA activity independently from cardiovascular risk factors and medical treatment. Homocysteine lowering therapies may increase fibrinolytic activity and thereby may help to avoid atherothrombotic events in patients with CAD after a first myocardial infarction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Walter Stefan Speidl, Mariam Nikfardjam, Alexander Niessner, Andrea Zeiner, Nelli Jordanova, Gerlinde Zorn, Gerald Maurer, Wolfgang Schreiber, Johann Wojta, Kurt Huber,